Besides their well‐known effect in the molting control in insects, ecdysteroids are steroid hormones that display potential pharmacologic and metabolic properties in mammals. The most common ecdysteroid, 20‐hydroxyecdysone (20E) is found in many plants such as quinoa. The aim of the present study was to investigate the ability of quinoa extract (Q) enriched in 20E supplementation to prevent the onset of diet‐induced obesity and to regulate the expression of adipocyte‐specific genes in mice. Mice were fed a standard low‐fat (LF) or a high‐fat (HF) diet with or without supplementation by 20E‐enriched Q or pure 20E for 3 weeks. Supplementation with Q reduced adipose tissue development in HF mice without modification of their body weight gain. This adipose tissue‐specific effect was mainly associated with a reduced adipocyte size and a decrease in the expression of several genes involved in lipid storage, including lipoprotein lipase and phosphoenolpyruvate carboxykinase. Furthermore, Q‐treated mice exhibited marked attenuation of mRNA levels of several inflammation markers (monocyte chemotactic protein‐1, CD68) and insulin resistance (osteopontin, plasminogen activator inhibitor‐1 (PAI‐1)) as compared to HF mice. Q supplementation also reversed the effects of HF‐induced downregulation of the uncoupling protein(s) (UCP(s)) mRNA levels in muscle. Similar results were obtained in mice fed a HF diet supplemented with similar amounts of pure 20E, suggesting that the latter accounted for most of the Q effects. Our study indicates that Q has an antiobesity activity in vivo and could be used as a nutritional supplement for the prevention and treatment of obesity and obesity‐associated disorders.

No abstract